학술논문
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial
Document Type
Article
Author
Source
In: European Urology . (European Urology, March 2024, 85(3):229-238)
Subject
Language
English
ISSN
18737560
03022838
03022838